Balkrishan Simba Gill
2017
In 2017, Balkrishan Simba Gill earned a total compensation of $1.8M as Chief Executive Officer at Evelo Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $218,720 |
|---|---|
| Option Awards | $1,175,550 |
| Salary | $437,500 |
| Total | $1,831,770 |
Gill received $1.2M in option awards, accounting for 64% of the total pay in 2017.
Gill also received $218.7K in non-equity incentive plan and $437.5K in salary.
Rankings
In 2017, Balkrishan Simba Gill's compensation ranked 5,926th out of 14,666 executives tracked by ExecPay. In other words, Gill earned more than 59.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,926 out of 14,666 | 60th |
Division Manufacturing | 2,162 out of 5,772 | 63rd |
Major group Chemicals And Allied Products | 674 out of 2,075 | 68th |
Industry group Drugs | 522 out of 1,731 | 70th |
Industry Pharmaceutical Preparations | 414 out of 1,333 | 69th |
Source: SEC filing on April 25, 2019.
Gill's colleagues
We found one more compensation record of an executive who worked with Balkrishan Simba Gill at Evelo Biosciences in 2017.
2017
Duncan MBBS
Evelo Biosciences
Chief Medical Officer
News
Evelo Biosciences Chief Development Officer Jonathan Zung receives $4.6M in 2021
April 26, 2022
Evelo Biosciences CEO Balkrishan Gill's 2020 pay falls 23% to $2.2M
April 26, 2021
Evelo Biosciences CEO Balkrishan Gill's 2019 pay falls 37% to $2.8M
April 27, 2020
Evelo Biosciences CEO Balkrishan Gill's 2018 pay jumps 144% to $4.5M
April 25, 2019